"Echocardiographic response" to sacubitril-valsartan: does it decrease defibrillation implantation, as well as the incidence of malignant arrhythmias? Response
Rev Esp Cardiol (Engl Ed). 2022 Jan;75(1):108.
doi: 10.1016/j.rec.2021.09.007.
Epub 2021 Oct 9.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Insuficiencia Cardiaca, Departamento de Cardiología, Hospital del Mar, Barcelona, Spain; Grup de Recerca Biomèdica en Malalties del Cor (GREC) de l'Institut del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. Electronic address: lbelarte@psmar.cat.
- 2 Departamento de Cardiología, Hospital del Mar, Barcelona, Spain.
- 3 Unidad de Insuficiencia Cardiaca, Departamento de Cardiología, Hospital del Mar, Barcelona, Spain; Grup de Recerca Biomèdica en Malalties del Cor (GREC) de l'Institut del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain; Departamento de Medicina, Facultad de Medicina, Universidad Autónoma de Barcelona, Barcelona, Spain.
No abstract available
MeSH terms
-
Aminobutyrates
-
Angiotensin Receptor Antagonists / therapeutic use
-
Arrhythmias, Cardiac / epidemiology
-
Biphenyl Compounds
-
Drug Combinations
-
Echocardiography*
-
Heart Failure* / epidemiology
-
Humans
-
Incidence
-
Stroke Volume
-
Tetrazoles
-
Valsartan
Substances
-
Aminobutyrates
-
Angiotensin Receptor Antagonists
-
Biphenyl Compounds
-
Drug Combinations
-
Tetrazoles
-
sacubitril
-
Valsartan